Another study deployed image-based profiling in primary chronic lymphatic leukemia (CLL) cells to identify small molecules effective in overcoming resistance against the BCL2 inhibitor Venetoclax [41]. The gene discussed is BCL2; the disease is B-cell chronic lymphocytic leukemia.